FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128728471> ?p ?o ?g. }

• W3128728471 endingPage "1021" @default.
• W3128728471 startingPage "1015" @default.
• W3128728471 abstract "Connective tissue diseases, including systemic sclerosis and idiopathic inflammatory myopathies (IIMs), are a very rare cause of thrombotic microangiopathies (TMAs). Whether dysregulation of the complement pathways underlies these secondary forms of TMA and may be targeted by complement blocking agents remains elusive.Kidney pathology and outcomes of 18 critically ill patients with TMA related to inflammatory myopathy flare-up (IIM, n=7) or scleroderma renal crisis (SRC, n=11; biopsy n=9) are assessed.IIM-TMA is characterized by acute thrombotic lesions only, whereas SRC-TMA patients also harbored chronic vascular lesions and more interstitial fibrosis. C5b9 deposits, a marker of complement component 5 (C5) cleavage, were observed in the 2 subgroups at the junction of media and intima of arterioles, colocalizing with subendothelial edema. Thus, kidney biopsy distinguished between acute and chronic renal phenotypes that may help to individualize treatment. Treatment of IIM-TMA patients with combined full-code organ support, corticosteroids, B-cell depletion, and complement C5 blocking led to 1-year survival of 72%, compared with 19% in historical cohorts. Treatment of SRC-TMA was more heterogenous and relied on conversion enzyme inhibitor only or with eculizumab (n=6) and immunosuppressor (n=5). One-year survival of SRC-TMA patients was 52%, a result similar to historical cohorts. Eculizumab was followed by a rapid dramatic improvement of TMA in all the treated patients.C5 blocking may reverse hematologic abnormalities in IIM- and SRC-TMA, and adding an early and aggressive immunosuppressive regimen may improve the survival of IIM-TMA. Underlying chronic vascular and interstitial lesions mitigate renal response in SRC-TMA." @default.
• W3128728471 created "2021-02-15" @default.
• W3128728471 creator A5000524184 @default.
• W3128728471 creator A5021846989 @default.
• W3128728471 creator A5025683973 @default.
• W3128728471 creator A5025924823 @default.
• W3128728471 creator A5036343171 @default.
• W3128728471 creator A5037789300 @default.
• W3128728471 creator A5040540371 @default.
• W3128728471 creator A5044263590 @default.
• W3128728471 creator A5058158092 @default.
• W3128728471 creator A5079224143 @default.
• W3128728471 creator A5085429142 @default.
• W3128728471 date "2021-04-01" @default.
• W3128728471 modified "2023-10-17" @default.
• W3128728471 title "Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies" @default.
• W3128728471 cites W1982003857 @default.
• W3128728471 cites W2076417190 @default.
• W3128728471 cites W2081031295 @default.
• W3128728471 cites W2081248108 @default.
• W3128728471 cites W2090499894 @default.
• W3128728471 cites W2179622030 @default.
• W3128728471 cites W2408113286 @default.
• W3128728471 cites W2488354037 @default.
• W3128728471 cites W2516089760 @default.
• W3128728471 cites W2523740842 @default.
• W3128728471 cites W2550881001 @default.
• W3128728471 cites W2552070532 @default.
• W3128728471 cites W2590258299 @default.
• W3128728471 cites W2745627401 @default.
• W3128728471 cites W2885188094 @default.
• W3128728471 cites W2885483179 @default.
• W3128728471 cites W2891778372 @default.
• W3128728471 cites W2898148941 @default.
• W3128728471 cites W2921983598 @default.
• W3128728471 cites W2922405587 @default.
• W3128728471 cites W2952270382 @default.
• W3128728471 cites W2979195286 @default.
• W3128728471 doi "https://doi.org/10.1016/j.ekir.2021.01.021" @default.
• W3128728471 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8071645" @default.
• W3128728471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33912751" @default.
• W3128728471 hasPublicationYear "2021" @default.
• W3128728471 type Work @default.
• W3128728471 sameAs 3128728471 @default.
• W3128728471 citedByCount "14" @default.
• W3128728471 countsByYear W31287284712021 @default.
• W3128728471 countsByYear W31287284712022 @default.
• W3128728471 countsByYear W31287284712023 @default.
• W3128728471 crossrefType "journal-article" @default.
• W3128728471 hasAuthorship W3128728471A5000524184 @default.
• W3128728471 hasAuthorship W3128728471A5021846989 @default.
• W3128728471 hasAuthorship W3128728471A5025683973 @default.
• W3128728471 hasAuthorship W3128728471A5025924823 @default.
• W3128728471 hasAuthorship W3128728471A5036343171 @default.
• W3128728471 hasAuthorship W3128728471A5037789300 @default.
• W3128728471 hasAuthorship W3128728471A5040540371 @default.
• W3128728471 hasAuthorship W3128728471A5044263590 @default.
• W3128728471 hasAuthorship W3128728471A5058158092 @default.
• W3128728471 hasAuthorship W3128728471A5079224143 @default.
• W3128728471 hasAuthorship W3128728471A5085429142 @default.
• W3128728471 hasBestOaLocation W31287284711 @default.
• W3128728471 hasConcept C111684460 @default.
• W3128728471 hasConcept C126322002 @default.
• W3128728471 hasConcept C142724271 @default.
• W3128728471 hasConcept C159654299 @default.
• W3128728471 hasConcept C180032290 @default.
• W3128728471 hasConcept C203014093 @default.
• W3128728471 hasConcept C2777637130 @default.
• W3128728471 hasConcept C2777878052 @default.
• W3128728471 hasConcept C2777991916 @default.
• W3128728471 hasConcept C2779134260 @default.
• W3128728471 hasConcept C2779967694 @default.
• W3128728471 hasConcept C71924100 @default.
• W3128728471 hasConceptScore W3128728471C111684460 @default.
• W3128728471 hasConceptScore W3128728471C126322002 @default.
• W3128728471 hasConceptScore W3128728471C142724271 @default.
• W3128728471 hasConceptScore W3128728471C159654299 @default.
• W3128728471 hasConceptScore W3128728471C180032290 @default.
• W3128728471 hasConceptScore W3128728471C203014093 @default.
• W3128728471 hasConceptScore W3128728471C2777637130 @default.
• W3128728471 hasConceptScore W3128728471C2777878052 @default.
• W3128728471 hasConceptScore W3128728471C2777991916 @default.
• W3128728471 hasConceptScore W3128728471C2779134260 @default.
• W3128728471 hasConceptScore W3128728471C2779967694 @default.
• W3128728471 hasConceptScore W3128728471C71924100 @default.
• W3128728471 hasIssue "4" @default.
• W3128728471 hasLocation W31287284711 @default.
• W3128728471 hasLocation W31287284712 @default.
• W3128728471 hasLocation W31287284713 @default.
• W3128728471 hasOpenAccess W3128728471 @default.
• W3128728471 hasPrimaryLocation W31287284711 @default.
• W3128728471 hasRelatedWork W2024870615 @default.
• W3128728471 hasRelatedWork W2034286783 @default.
• W3128728471 hasRelatedWork W2077986770 @default.
• W3128728471 hasRelatedWork W2140370443 @default.
• W3128728471 hasRelatedWork W2141534367 @default.
• W3128728471 hasRelatedWork W2897797027 @default.
• W3128728471 hasRelatedWork W2904881915 @default.

• next